NWL:ASXNetwealth Group Ltd. Analysis
Data as of 2026-03-15 - not real-time
A$21.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Netwealth (NWL) is trading at AUD 21.5, well below its 20‑day (24.29) and 50‑day (24.55) SMAs and far under the DCF‑derived fair value of AUD 28.21, implying a potential upside of roughly 30%. Fundamentally the company delivered 23.8% revenue growth, gross margins of 66% and operating margins near 49%, while generating AUD 141 m of operating cash flow and a free cash flow of AUD 189 m, underscoring a robust earnings engine. However, the stock shows a bearish technical picture – MACD is negative, RSI sits at 35 (approaching oversold), and volume is decreasing, with a 30‑day volatility of 69% and beta of 1.25, indicating heightened price swings. Recent half‑year earnings highlighted record inflows, with funds under administration rising 23.6% to AUD 125.6 bn and net new flows of AUD 8.2 bn, reinforcing the growth narrative but the dividend payout ratio of 166% flags sustainability concerns.
Analyst consensus remains a “Buy” with a median target of AUD 28.63, suggesting the market still sees upside, yet the current PE of 93× versus an industry average of 34× and a price‑to‑book of 35× point to a premium valuation. Investors must weigh the strong cash generation and growth against the elevated volatility, bearish short‑term momentum, and an unsustainable dividend policy.
Analyst consensus remains a “Buy” with a median target of AUD 28.63, suggesting the market still sees upside, yet the current PE of 93× versus an industry average of 34× and a price‑to‑book of 35× point to a premium valuation. Investors must weigh the strong cash generation and growth against the elevated volatility, bearish short‑term momentum, and an unsustainable dividend policy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and RSI near oversold levels
- Price at immediate support around AUD 21.08
- High short‑term volatility and decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- Record inflows and expanding funds under administration
- DCF fair value indicating ~30% upside and analyst target around AUD 28.5
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable high ROE and ROA indicating competitive advantage
- Continued platform adoption and potential for further fee‑based revenue
- Valuation premium offset by growth trajectory, though dividend policy remains a risk
Key Metrics & Analysis
Financial Health
Revenue Growth23.80%
Profit Margin15.71%
P/E Ratio93.5
ROE34.57%
ROA41.82%
Debt/Equity8.37
P/B Ratio35.2
Op. Cash FlowA$141.3M
Free Cash FlowA$189.4M
Industry P/E33.7
Technical Analysis
TrendBearish
RSI35.6
SupportA$21.08
ResistanceA$27.43
MA 20A$24.29
MA 50A$24.55
MA 200A$29.96
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueA$28.21
Target PriceA$28.14
Upside/Downside30.89%
GradeUndervalued
TypeGrowth
Dividend Yield1.95%
Risk Assessment
Beta1.25
Volatility69.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.